Oppenheimer Reiterates Outperform Rating on Rhythm Pharmaceuticals (RYTM)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/18/2026
- Wall Street tumbles as worries about AI trade and high oil prices weigh
- Oil touches $110 a barrel for first time since May on Middle East, Russia supply fears
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
| (NASDAQ: RYTM) | Delayed: 86.17 -1.8 (2.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $87.97 | 52 Week High | $ | |||
| Open | $88.20 | 52 Week Low | $ | |||
| Day High | $88.62 | P/E | N/A | |||
| Day Low | $85.91 | EPS | $ | |||
| Volume | 367,036 | |||||
